The results, if they hold up, are likely to result in many patients getting the medicine, and could upend decades of orthodoxy among cardiologists.
In Blowout, Amarin’s Fish-Oil-Derived Drug Dramatically Cuts Heart Risk In Study
The results, if they hold up, are likely to result in many patients getting the medicine, and could upend decades of orthodoxy among cardiologists.